Abstract

Friedreich’s ataxia (FRDA) is a multi-faceted disease characterized by progressive sensory–motor loss, neurodegeneration, brain iron accumulation, and eventual death by hypertrophic cardiomyopathy. FRDA follows loss of frataxin (FXN), a mitochondrial chaperone protein required for incorporation of iron into iron–sulfur cluster and heme precursors. After the discovery of the molecular basis of FRDA in 1996, over two decades of research have been dedicated to understanding the temporal manifestations of disease both at the whole body and molecular level. Early research indicated strong cellular iron dysregulation in both human and yeast models followed by onset of oxidative stress. Since then, the pathophysiology due to dysregulation of intracellular iron chaperoning has become central in FRDA relative to antioxidant defense and run-down in energy metabolism. At the same time, limited consideration has been given to changes in cytoskeletal organization, which was one of the first molecular defects noted. These alterations include both post-translational oxidative glutathionylation of actin monomers and differential DNA processing of a cytoskeletal regulator PIP5K1β. Currently unknown in respect to FRDA but well understood in the context of FXN-deficient cell physiology is the resulting impact on the cytoskeleton; this disassembly of actin filaments has a particularly profound effect on cell–cell junctions characteristic of barrier cells. With respect to a neurodegenerative disorder such as FRDA, this cytoskeletal and tight junction breakdown in the brain microvascular endothelial cells of the blood–brain barrier is likely a component of disease etiology. This review serves to outline a brief history of this research and hones in on pathway dysregulation downstream of iron-related pathology in FRDA related to actin dynamics. The review presented here was not written with the intent of being exhaustive, but to instead urge the reader to consider the essentiality of the cytoskeleton and appreciate the limited knowledge on FRDA-related cytoskeletal dysfunction as a result of oxidative stress. The review examines previous hypotheses of neurodegeneration with brain iron accumulation (NBIA) in FRDA with a specific biochemical focus.

Highlights

  • The Molecular Basis of Friedreich’s ataxia (FRDA): The Essentiality of FrataxinFRDA arises from a failure of transcription and posttranscriptional processing of the frataxin (FXN) gene

  • Its function is specific to the inner mitochondrial compartment where it acts as an iron chaperone protein, facilitating assembly of iron–sulfur clusters (ISC) and the metalation of protoporphyrin IX in the biosynthesis of heme (Rötig et al, 1997; Park et al, 2003; Bulteau et al, 2004; Yoon and Cowan, 2004; Cai et al, 2018)

  • ISCs are essential to energy metabolism in the electron transport chain (ETC)

Read more

Summary

Introduction

The Molecular Basis of FRDA: The Essentiality of FrataxinFRDA arises from a failure of transcription and posttranscriptional processing of the frataxin (FXN) gene. Mouse models lack consistency to human disease by exhibiting increased transferrin-bound iron in the serum, which in the model of cardiac and skeletal muscle FXN-deficient mice may reflect physiological iron concentrations and function of all other organ and tissue systems (Whitnall et al, 2012).

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call